Shot in the arm for GSK and AstraZeneca from cancer drug sales The blue chip drug makers saw first quarter earnings beat market expectations. Evening Standard · Apr 29
Blue chips close lower amid US-Iran stalemate For the week, the FTSE 100 fell 2.7%, the FTSE 250 also declined 2.7% and the AIM All-Share dipped 1.7%. Evening Standard · Apr 24
‘My husband had the Covid-19 vaccine – 11 days later he was dead’ Stephen Ward developed a blood clot after a dose of AstraZeneca The Independent UK · Apr 16
GSK reports promising early results in ovarian and womb cancer drug trial Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug The Guardian - UK · Apr 12
FTSE 100 ends down as oil rises while Iran war remains in deadlock The FTSE 100 closed down just 4.82 points at 9,967.35. Evening Standard · Mar 27
‘We were told it was safe’: Inside the legal battle over Covid vaccine deaths in India IN FOCUS: In a landmark ruling, India’s top court orders a compensation framework for victims of rare but potentially deadly side effects following Covid vaccination. It’s a victory for families – but questions about transparency, consent and trust remain unresolved. Namita Singh reports The Independent UK · Mar 26
Chinese-owned Syngenta to build new £100m bioscience hub in UK Agrichemical group will open a research centre in Berkshire, in a move hailed by UK government as ‘clear’ vote of confidence The Guardian - UK · Mar 16
Sir Ronnie Hampel obituary Chief executive and chairman of ICI in the 1990s who oversaw the creation of the pharmaceutical company Zeneca The Guardian - UK · Mar 11
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn UK’s GSK is leading the way in research but AstraZeneca is not involved in the area, report finds The Guardian - UK · Mar 10
COVID vaccination: we now may know why some people developed blood clots COVID vaccines saved millions of lives, but months into the rollout, a small number of people began developing dangerous blood clots in unusual parts of the body. These only happened after vaccines that used a modified adenovirus to deliver its payload – such as the AstraZeneca vaccine. Why these blood… The Conversation · Mar 9
Emma Walmsley’s pay rose almost 50% to £15.6m in final year as GSK boss Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise The Guardian - UK · Mar 5
Hannah Spencer: the Green MP speaking to everyday people’s frustrations Winner of Gorton and Denton byelection was driven into politics by growing gap between super-rich and the ‘rest of us’ The Guardian - UK · Feb 27
HSBC reclaims top spot as FTSE 100 hits new high The FTSE 100 index ended up 1.2% at 10,806.41, a record close. Evening Standard · Feb 25
AstraZeneca boss Pascal Soriot nets £17.7m in pay and bonuses for 2025 The drug maker’s annual report showed his total pay lifted 6.4% last year after he was awarded nearly £16 million in bonuses and share awards. Evening Standard · Feb 24
The Guardian - UK · Feb 24 AstraZeneca boss Pascal Soriot’s pay rises to £17.7m Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects
AAP · Feb 16 Cheaper diabetes drug halted by AstraZeneca court win Consumers will have to wait longer for a more affordable diabetes and heart failure drug after pharmaceutical giant AstraZeneca had a win in court.
The Guardian - UK · Feb 15 Weight-loss race: how switch from injections to pills is expanding big pharma’s hopes Tablets could make treatment more mainstream, with sector predicted to be worth $200bn by end of the decade
MarketBeat · Feb 12 A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month.
The Guardian - UK · Feb 10 AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site
Evening Standard · Feb 10 AstraZeneca profits jump by 40% amid strong demand for cancer drugs Shares edged 1% higher in morning trading on Tuesday, with the stock having risen 28% in the past six months.
The Guardian - UK · Feb 4 GSK, take two: the bullish tone at the top is finally more convincing New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential
Evening Standard · Feb 2 FTSE 100 sets new record despite metals meltdown Gold was quoted lower at 4,696.11 dollars an ounce on Monday, down sharply against 5,003.82 dollars at the same time on Friday.
Evening Standard · Feb 2 AstraZeneca shares launch on New York Stock Exchange The UK based-pharmaceutical giant is transitioning to the market by delisting American Depositary Shares from the Nasdaq index.
Evening Standard · Jan 30 AstraZeneca secures tie-up with Chinese firm for weight loss drugs The deal includes giving AstraZeneca access to the exclusive global rights, outside China, to CSPC’s once-a-month weight management jabs.
Evening Standard · Jan 30 FTSE 100 Live 30 January: Gold and silver prices slump, AstraZeneca strikes China deal The price of gold today fell back as traders focused on President Trump’s nomination as next Federal Reserve chair.